HOUSTON — In a groundbreaking move, the FDA has approved the second phase of clinical trials for the BiVACOR mechanical heart, a device that could potentially make human heart transplants a thing of ...

As part of a five-patient FDA Early Feasibility Study, BiVACOR TAH successfully bridges all five patients to a donor heart transplant. Data supports the expansion of the Early Feasibility Study to 20 ...

The BiVACOR Total Artificial Heart (TAH) is a compact, titanium-constructed device about the size of a fist. Despite its small stature, it packs a powerful punch. It can pump blood at a rate of 12 ...

The BiVACOR Total Artificial Heart has a single moving part – a levitated rotor that’s held in place by magnets. - BiVACOR An Australian man lived for 100 days with an artificial titanium heart while ...

HUNTINGTON BEACH, Calif. & HOUSTON & GOLD COAST, Australia--(BUSINESS WIRE)--BiVACOR, Inc., a clinical-stage medical technology company developing a total artificial heart (TAH), today announced that ...

HUNTINGTON BEACH, Calif.--(BUSINESS WIRE)--BiVACOR, Inc., a clinical-stage medical technology company developing a total artificial heart (TAH), today announced that Raymond W. Cohen has been ...

On a scale of cardiac density that begins with Blondie’s heart of glass and ends with the Rolling Stones’ heart of stone, Houston-based startup Bivacor’s artificial ticker falls somewhere in the ...

The US Food and Drug Administration (FDA) has approved the expansion of BiVACOR’s early feasibility study evaluating its titanium total artificial heart (TAH) to additional participants. The decision ...

Outside of the brain, the heart is probably the organ that you miss the most when it ceases to function correctly. Unfortunately, as we cannot grow custom replacement hearts yet, we have to keep heart ...

Add Yahoo as a preferred source to see more of our stories on Google. A 58-year-old man in the United States is the first person in the world to have had his failing heart replaced with a temporary, ...